Loading live market data…

GE HealthCare Technologies Inc.

NASDAQ:GEHC

$63.2 USD

$1.54 (2.5%)

Volume
6.14M
Average Volume
5.23M
Market Capitalization
$28.75B
P/E Ratio
19.15
Dividend Yield
0.22%
Price Target
$80.00
Year High
$89.77
Year Low
$58.75
Day High
Day Low
Payout Ratio
$0.04
Current Ratio
$1.17
Source Headline
Do Options Traders Know Something About GE HealthCare Stock We Don't?

Investors need to pay close attention to GEHC stock based on the movements in the options market lately.

zacks.com - 2026-07-14 11:51:08

GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics

GEHC and Mayo Clinic collaboration aims to advance adaptive cancer theranostics using imaging, biomarkers and clinical data from the MI-BET study.

zacks.com - 2026-07-09 14:37:04

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, July 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws.   IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC.

prnewswire.com - 2026-07-08 15:00:00

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa., July 8, 2026 /PRNewswire/ -- Law Offices of Howard G.

prnewswire.com - 2026-07-08 09:00:00

GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration

CHICAGO & ROCHESTER, Minn.--(BUSINESS WIRE)--GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Therapy Trial) research collaboration, a novel theranostics study designed to explore a more personalized approach to radioligand therapy (RLT) for patients with advanced prostate cancer. This collaboration is a direct result of the 2023 Strategic Radiology Research Alliance between Mayo Clinic and GE HealthCare, aimed at transforming the experience of.

businesswire.com - 2026-07-08 09:00:00

GE HealthCare to announce second quarter 2026 results on July 29, 2026

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its second quarter 2026 financial results before the market opens on Wednesday, July 29, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will.

businesswire.com - 2026-07-08 08:00:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES, July 7, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.

prnewswire.com - 2026-07-07 19:25:00

GE HealthCare announces cash dividend for second quarter of 2026

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2026 payable on August 14, 2026, to all shareholders of record as of July 24, 2026.About GE HealthCare Technologies Inc.GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle.

businesswire.com - 2026-06-30 14:20:00

GEHC Launches Allia Upgrade Pathways for Interventional Suites

GE HealthCare's Allia upgrade pathways let providers modernize legacy imaging systems with AI-enabled workflows while reducing construction and disruption.

zacks.com - 2026-06-30 10:52:22

GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced Allia™ platform upgrade pathways designed to help customers modernize select legacy Innova™ and Discovery™ Image Guiding Solutions (IGS) systems. These pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime, and minimize disruption to clinical operations. As procedura.

businesswire.com - 2026-06-29 09:00:00

Here Are Tuesday's Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More

Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday.

247wallst.com - 2026-06-23 07:59:18

GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia

GE HealthCare expands its Carilion Clinic collaboration with AAMP and Encompass to improve equipment management and operational efficiency across Virginia.

zacks.com - 2026-06-15 11:50:25

GE HealthCare advancing enterprise imaging with cloud-enabled solutions

CHICAGO--(BUSINESS WIRE)--GE HealthCare will showcase its latest enterprise imaging solutions at the Society for Imaging Informatics in Medicine (SIIM) 2026 Annual Meeting in Pittsburgh, PA. Medical imaging departments today are under immense pressure from all sides including rising imaging volumes and increasing case complexity, while staffing shortages continue to grow. According to the American College of Radiology (ACR), radiologist workforce shortages have been identified as the biggest th.

businesswire.com - 2026-06-09 09:00:00

GE HealthCare Gains FDA Clearance for AI Radiation Planning Software

GEHC wins FDA clearance for AI-powered radiation planning software, adding new clinical models and a pathway for faster future updates.

zacks.com - 2026-06-05 10:25:38

GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI-enabled auto-contouring software to assist radiation oncology care teams with treatment planning. This can help clinicians reduce treatment planning time, enabling them to focus on delivering more timely and personalized care for patients. The FDA clearance includes a Predetermined Change Control.

businesswire.com - 2026-06-04 08:00:00

GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-03 10:42:03

GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations

CHICAGO--(BUSINESS WIRE)--As theranostics adoption acceleratesi and radiopharmaceutical demand grows,ii healthcare systems are under increasing pressure to scale nuclear medicine operations while improving diagnostic confidence and workflow efficiency. At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare showcases its latest technologies and AI-enabled workflows to help support precision care across care pathways. Nuclear medicine is undergoing rap.

businesswire.com - 2026-06-01 08:10:00

GE HealthCare Technologies: Doing Some Bottom Fishing

GE HealthCare Technologies: Doing Some Bottom Fishing

seekingalpha.com - 2026-06-01 06:20:59

GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?

GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-29 12:32:16

GE HealthCare and UW Medicine Radiology Expand CT, MI Research Tie

GEHC teams with UW Medicine Radiology to advance CT and molecular imaging, aiming to automate workflows and speed next-gen imaging to clinics.

zacks.com - 2026-05-25 12:01:26

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to di.

businesswire.com - 2026-05-22 17:00:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues -- Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

[url="]The Law Offices of Frank R. Cruz[/url] continues its investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:

gurufocus.com - 2026-05-22 16:00:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On April 29, 2026, GE HealthCare repor.

businesswire.com - 2026-05-22 15:00:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues -- Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Fi

[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technolo

gurufocus.com - 2026-05-22 14:00:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened.

businesswire.com - 2026-05-22 13:22:00

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.

globenewswire.com - 2026-05-21 19:00:00

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices.

globenewswire.com - 2026-05-21 19:00:00

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

The law firm of [url="]Kirby McInerney LLP[/url] continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Compan

gurufocus.com - 2026-05-19 21:00:00

GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 29, 2026, GE HealthCare reported its financial results for the first quarter of 2026. A.

businesswire.com - 2026-05-19 20:00:00

Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options

globenewswire.com - 2026-05-19 18:41:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Announced -- Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Fi

[url="]Glancy Prongay Wolke and Rotter LLP[/url], a leading national shareholder rights law firm, today announced that it has commenced an investigation on behal

gurufocus.com - 2026-05-18 16:00:00

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOV.

businesswire.com - 2026-05-18 15:00:00

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith announces an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: [url=

gurufocus.com - 2026-05-18 14:00:00

GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.Contact the Law Offices of Howard G. Smith to dis.

businesswire.com - 2026-05-18 13:39:00

GE HealthCare Technologies Sticks to Growth Story After Inflation-Driven Guidance Cut

GE HealthCare Technologies NASDAQ: GEHC executives said the company remains confident in its long-term growth prospects despite a disappointing first quarter that led to a reduction in full-year guidance, citing inflationary cost pressures as the primary near-term challenge.

marketbeat.com - 2026-05-17 06:05:31

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company's possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON GE HEALTHCARE TECHNOLOGIES INC. (GEHC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On April 29, 2026, GE HealthCare report.

businesswire.com - 2026-05-15 16:57:00

GEHC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.

globenewswire.com - 2026-05-14 19:00:00

GE HEALTHCARE STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options

globenewswire.com - 2026-05-14 18:24:00

GE HEALTHCARE TECHNOLOGIES INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On April 29, 2026, GE HealthCare reported its financial results for the first quar.

businesswire.com - 2026-05-12 20:00:00

GE HealthCare Technologies Inc. (GEHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

GE HealthCare Technologies Inc. (GEHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-12 17:50:47

GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools

GEHC unveils AI-powered MRI innovations at ISMRM 2026, expanding imaging speed, quality and research collaboration tools.

zacks.com - 2026-05-12 11:40:39

ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions

CHICAGO--(BUSINESS WIRE)--At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company's presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care. According to the World H.

businesswire.com - 2026-05-12 09:00:00

GEHC Launches MIM ComboTherapy for GYN Cancer Radiation Planning

GE HealthCare launches MIM ComboTherapy to improve radiation planning for gynecologic cancers with advanced dose visualization.

zacks.com - 2026-05-11 11:06:24

GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact

CHICAGO--(BUSINESS WIRE)--As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements. GE HealthCare continues to invest in advanced MR technology with its next-generation SI.

businesswire.com - 2026-05-11 09:00:00

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GE HealthCare Technologies Inc. - GEHC

NEW YORK, May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GE HealthCare Technologies Inc. ("GE HealthCare" or the "Company") (NASDAQ: GEHC).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

prnewswire.com - 2026-05-07 10:00:00

Here's Why GE Healthcare Shares Slumped This Week

GE Healthcare's stock dropped 11.3% after Q1 2026 earnings. Rising costs are pressuring margins, leading to lowered EPS guidance.

fool.com - 2026-05-02 13:17:31

GE HealthCare Technologies Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of GE HealthCare Technologies Inc. (NASDAQ: GEHC). The investigation focuses on GE HealthCare's executive officers and whether investor losses may be recovered under federal securities laws.

globenewswire.com - 2026-04-30 19:15:00

GE HealthCare Just Crashed 13% on a Guidance Cut. Here's the Case for Buying the Dip

GE HealthCare (NASDAQ: GEHC | GEHC Price Prediction) currently trades at $59.49, well below the Wall Street consensus price target of $89.74.

247wallst.com - 2026-04-30 08:05:35

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices except the Nasdaq end lower, with the Nasdaq closing virtually unchanged at 24,603, up 0.04%. The combination of soaring oil prices, the Federal Reserve keeping interest rates unchanged for the third straight meeting, and bogged-down... Here Are Thursday's Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

247wallst.com - 2026-04-30 07:49:34

GE HealthCare Q1 2026: Inflation And Execution Risks Weigh On Outlook

GE HealthCare Technologies is rated a hold following 1Q26, reflecting resilient demand but significant near-term margin pressure. GEHC maintains a robust $21.8B backlog and credible innovation pipeline, supporting mid-single-digit revenue growth, yet faces execution risk from lagged pricing actions. Profitability was hit by $250M in inflation headwinds, tariffs, and Patient Care Solutions weakness, leading to a downward revision in adjusted EPS guidance to $4.80–$5.00.

seekingalpha.com - 2026-04-30 07:10:29

Get GEHC Insider Trade Alerts

GEHC Price Target Summary

Last Month

$75.00

3 analysts

Last Quarter

$77.00

10 analysts

Last Year

$85.11

27 analysts

All Time

$87.98

42 analysts

GEHC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-05-21 UBS Upgrade Sell Neutral
2026-04-30 Goldman Sachs Downgrade Buy Neutral
2026-04-30 Evercore ISI Group Maintain Outperform Outperform
2026-04-30 JP Morgan Maintain Neutral Neutral
2026-04-30 Wells Fargo Maintain Overweight Overweight
2026-04-30 Citigroup Maintain Neutral Neutral
2026-04-30 Barclays Maintain Equal Weight Equal Weight
2026-04-29 BTIG Maintain Buy Buy
2026-04-21 BTIG Maintain Buy Buy
2026-04-17 Piper Sandler Maintain Overweight Overweight
2026-04-13 Mizuho Maintain Outperform Outperform
2026-04-09 Goldman Sachs Maintain Buy Buy
2026-04-06 Evercore ISI Group Maintain Outperform Outperform
2026-03-26 Piper Sandler Maintain Overweight Overweight
2026-03-19 BTIG Maintain Buy Buy
2026-03-11 Citigroup Maintain Neutral Neutral
2026-02-09 BTIG Maintain Buy Buy
2026-02-06 Barclays Maintain Equal Weight Equal Weight
2026-02-05 Evercore ISI Group Maintain Outperform Outperform
2026-02-05 Morgan Stanley Maintain Equal Weight Equal Weight
2026-02-05 Stifel Maintain Buy Buy
2026-02-05 Wells Fargo Maintain Overweight Overweight
2026-02-04 BTIG Maintain Buy Buy
2026-01-30 Piper Sandler Maintain Overweight Overweight
2026-01-15 UBS Downgrade Neutral Sell
2026-01-07 Stifel Maintain Buy Buy
2026-01-05 B of A Securities Maintain Neutral Neutral
2025-12-11 Citigroup Maintain Neutral Neutral
2025-12-11 Jefferies Maintain Buy Buy
2025-11-21 BTIG Maintain Buy Buy
2025-10-30 Evercore ISI Group Maintain Outperform Outperform
2025-10-30 Wells Fargo Maintain Overweight Overweight
2025-10-30 Morgan Stanley Maintain Equal Weight Equal Weight
2025-10-13 BTIG Maintain Buy Buy
2025-10-07 Citigroup Downgrade Buy Neutral
2025-07-31 Citigroup Maintain Buy Buy
2025-07-31 Morgan Stanley Maintain Equal Weight Equal Weight
2025-07-09 Citigroup Maintain Buy Buy
2025-05-06 Morgan Stanley Maintain Equal Weight Equal Weight
2025-05-05 UBS Upgrade Sell Neutral
2025-05-01 Goldman Sachs Maintain Buy Buy
2025-05-01 Evercore ISI Group Maintain Outperform Outperform
2025-05-01 Wells Fargo Maintain Overweight Overweight
2025-04-30 Citigroup Maintain Buy Buy
2025-04-23 Piper Sandler Maintain Overweight Overweight
2025-03-11 Goldman Sachs Upgrade Neutral Buy
2025-02-14 Wells Fargo Maintain Overweight Overweight
2025-02-13 Citigroup Maintain Buy Buy
2025-01-08 Jefferies Upgrade Hold Buy
2024-10-31 Wells Fargo Maintain Overweight Overweight
2024-10-01 Evercore ISI Group Maintain Outperform Outperform
2024-09-30 Stifel Maintain Buy Buy
2024-09-26 UBS Downgrade Neutral Sell
2024-09-18 BTIG Upgrade Neutral Buy
2024-05-01 B of A Securities Maintain Neutral Neutral
2024-05-01 Mizuho Maintain Buy Buy
2024-04-11 Mizuho Maintain Buy Buy
2024-04-04 Evercore ISI Group Maintain Outperform Outperform
2024-04-03 Citigroup Maintain Buy Buy
2024-04-01 Argus Research Maintain Buy Buy
2024-02-12 UBS Upgrade Sell Neutral
2024-02-12 Morgan Stanley Maintain Equal Weight Equal Weight
2024-02-07 Mizuho Maintain Buy Buy
2023-12-04 Morgan Stanley Maintain Equal Weight Equal Weight
2023-11-27 UBS Downgrade Neutral Sell
2023-07-26 Morgan Stanley Maintain Equal Weight Equal Weight
2023-05-16 Oppenheimer Maintain Outperform Outperform
2023-04-26 Mizuho Maintain Buy Buy
2023-04-26 UBS Maintain Neutral Neutral
2023-04-19 Piper Sandler Maintain Overweight Overweight
2023-04-18 Mizuho Maintain Buy Buy
2023-04-10 BTIG Maintain Neutral Neutral
2023-03-13 Evercore ISI Group Maintain Outperform Outperform
2023-02-17 Mizuho Maintain Buy Buy
2023-01-19 Redburn Partners Maintain Buy Buy
2023-01-04 Edward Jones Maintain Hold Hold